Login
Home / KEQU : NASDAQ
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Kewaunee Scientific Corporation

$35.91 -$1.59 (-4.24%)
NASDAQ · 14 Sep 2026 15:24 UTC
Previous Close
$34.45
Day Range
$34.01$35.91
Year Range
$32$46.7
Market Cap
103.01M
AVG Volume
4.2K
Trailing/Forward PE
12.56/16.63
PEG ratio
0.3
Dividend Yield
-
Next Earnings Date
2026-12-16
Primary Exchange
NASDAQUS
Revenue (USD)
020M40M60M80M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Net Income (USD)
05M10M15M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Operating Income (USD)
02.5M5M7.5M10M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EBITDA (USD)
02.5M5M7.5M10M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Cash Flows (USD)
-10M-5M05M10M15M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EPS (USD)
0123424 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Expenses (USD)
05M10M15M20MR&DSG&ACapex24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Cash & Debt (USD)
020M40M60MCashLong Term DebtShort Term Debt24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Debt ratios
-202424 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Margins
0%10%20%30%40%24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Return on Capital
0%5%10%15%20%24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Shares Outstanding
01M2M3M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Dividends (USD)
00.050.10.150.2Jun 17Sep 17Dec 17Mar 18Jun 18Sep 18Dec 18Mar 19Jun 19Sep 19
Employee Count
02004006008001995199619972023202420252026
Book Value Per Share (USD)
010203024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Total Assets (USD)
050M100M150M200M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
PE Ratio
2.557.51012.515med 9.54Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Free Cash Flow Yield
0%5%10%15%20%med 8.65%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
0.20.40.60.81med 0.45Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EV/EBITDA
2.557.51012.515med 5.63Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price/Operating Cashflow
0102030med 9.74Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Book
11.522.533.5med 1.66Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Kewaunee Scientific Corporation
KEQU
Stockpicker

Video analysis: KEQU

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: KEQU

Kewaunee Q1 Earnings Fall Y/Y Despite International Strength

zacks.com · 10 Sep 2026

Kewaunee Q1 Earnings Fall Y/Y Despite International Strength

KEQU's fiscal Q1 results reflect weaker sales and LPG volumes, partly offset by stronger international profitability and cost control.
Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2027

prnewswire.com · 9 Sep 2026

Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2027

STATESVILLE, N.C., Sept. 9, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its first quarter ended July 31, 2026.
Kewaunee Scientific Posts Record $282M Revenue, Maps Fiscal 2027 Growth Investments

marketbeat.com · 29 Aug 2026

Kewaunee Scientific Posts Record $282M Revenue, Maps Fiscal 2027 Growth Investments

Kewaunee Scientific NASDAQ: KEQU reported record revenue and outlined continued investments in product development, manufacturing capacity, international expansion and potential acquisitions during its 2026 annual meeting of stockholders.
Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2027

prnewswire.com · 25 Aug 2026

Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2027

STATESVILLE, N.C., Aug. 25, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its first quarter fiscal year 2027 financial results on Wednesday, September 9, 2026 after the close of trading.
Kewaunee Scientific Q4 Earnings & Sales Fall Y/Y on Project Timing

zacks.com · 29 Jun 2026

Kewaunee Scientific Q4 Earnings & Sales Fall Y/Y on Project Timing

KEQU posts lower Q4 sales and EPS as project timing and Middle East shipment delays weigh on the results despite annual revenue growth.
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter

prnewswire.com · 23 Jun 2026

Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter

STATESVILLE, N.C., June 23, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fiscal year and fourth quarter ended April 30, 2026.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.